Companies / BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc.
Nasdaq: BTAICIK 1720893NEW HAVEN, CT
Insider flow ยท last 90 daysNet sells $7.4K
Financials ยท FY2025
Ownership
30.9M shares outstanding ยท as of May 14, 2026
Ownership
| Insiders | 0.18% | 54,457 |
| 10%+ / strategic | 0.51% | 156,066 |
| Institutions | 12.65% | 3,905,596 |
| Public float | 86.67% | 26,761,486 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all โ| Insider | % of shares | Shares |
|---|---|---|
Steinhart Richard IChief Financial Officer | 0.09% | 26,335 |
Mehta VimalCEOCEO and President ยท Director | 0.07% | 21,259 |
Rodriguez JavierSee Remarks | 0.02% | 6,863 |
Yocca FrankFormerChief Scientific Officer | 0.02% | 6,520 |
Bray JuneDirector | โ | โ |
Laumas SandeepDirector | โ | โ |
Mack David J.Director | โ | โ |
Miller Michael PatrickDirector | โ | โ |
Mueller PeterDirector | โ | โ |
Patni RajivDirector | โ | โ |
Institutional holders 46
View all โ| Holder | Value | % of shares |
|---|---|---|
| $2.60M | 6.27% | |
| $468.4K | 0.95% | |
| $385.9K | 0.78% | |
| $308.7K | 0.75% | |
| $253.0K | 0.58% | |
| $220.3K | 0.45% | |
| $204.0K | 0.41% | |
| $144.5K | 0.29% | |
| $129.9K | 0.30% | |
| $108.4K | 0.26% |
Activity
Jun 30, 2026View all โ
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares ฮ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2023 as of | Barclays PLC 13F manager | Add | Common stock | $949.6K | +51K +990.79% | 56,023 0.18% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | Add | Common stock | $297.7K | +45K +79.78% | 100,720 0.33% of shares | low |
| Q3 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-235.5K | -93K -92.40% | 7,656 0.02% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common Stock | $136.1K | +102K +5.53% | 1,936,760 6.27% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $134.0K | +95K +112.61% | 179,433 0.58% of shares | low |
| Q1 2026 as of | &Partners 13F manager | New | Common Stock | $108.4K | +81K | 80,864 0.26% of shares | low |
| Q4 2023 as of | Barclays PLC 13F manager | Add | Common stock | $59.7K | +20K +264.35% | 27,895 0.09% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | New | Common Stock | $53.6K | +38K | 38,038 0.12% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Integrated Core Strategies (US) LLC | Passive13G/A | โ |
| Qatar Investment Authority | Passive13G/A | โ |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| BTAI | Common Stock | 09075P204 |
| BTAI | โ | 09075P105 |